Genescient Corporation receives an additional $500,000 in angel funding. - December 17, 2009
New study suggests that, when long-term effects are considered, two commonly ingested stimulants are not created equal. - August 19, 2009
Genescient Corporation and Kronos Science Laboratory will work together to analyze the Kronos Alzheimer's Case-Control Database, considered to be the finest Alzheimer's Disease genetic data set in the US. The companies hope to identify genes previously unrecognized genes that are involved in Alzheimer's Disease. - March 04, 2009
